AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Ark Invest Shifts Focus, Trims Tesla Holdings by $30 Million
ByAinvest
Monday, Dec 29, 2025 11:29 am ET1min read
CRSP--
PACB--
TSLA--
WRD--
ARK--
Ark Invest has increased its exposure to gene-editing and autonomous mobility sectors, reducing its Tesla holdings by 60,715 shares valued at $30 million. The firm acquired shares of CRISPR Therapeutics and Pacific Biosciences, and added shares of WeRide in the autonomous mobility sector. Ark trimmed positions in Cloudflare, Palantir, Roku, and Shopify. Tesla reported a revenue of $95.63 billion with a three-year revenue growth rate of 20.7%. The company's operating margin is 5.09%, net margin is 5.31%, and gross margin is 17.01%.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc's editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet